Context
Addressing vitamin D deficiency (VDD) is important for fracture secondary prevention.
Objectives
To explore the function of a Fracture Liaison Service (FLS) to address VDD.
Design, Setting and Patients
An observational study of patients admitted to the Massachusetts General Hospital (MGH) with fractures between 1/1/2016 and 10/31/2023 cared for by the FLS.
Intervention
Ergocalciferol 50,000 international units (50ku-D2) oral daily for 3-7 days.
Main Outcomes Measures
VDD prevalence. Efficacy of inpatient daily 50ku-D2 in raising serum 25-hydroxyvitamin D (25OHD) levels.
Results
Of the 2951 consecutive patients, 724 (24.53%) had VDD (defined by 25OHD ≤ 19 ng/ml). Men (252/897, or 28.09%) were more likely than women (472/2054, or 22.98%) to have VDD (p = 0.003). VDD was seen in 41.79% (117/280), 24.41% (332/1360) and 20.98% (275/1311) of patients of ≤59, 60-79, and ≥80 years old, respectively (p < 0.00001).
Of the 1303 patients with hip fractures, 327(25.09%) had VDD, which was associated with a longer length-of-stay (LOS) (8.37 ± 7.35 vs. 7.23 ± 4.78 days, p = 0.009) and higher trend of 30-day-readmission (30d-RA) rate (13.63% vs. 18.35%, p = 0.037).
In a cohort of 32 patients with complete data, each dose of 50ku-D2 increased serum 25OHD by 3.62 ± 2.35 ng/ml without affecting serum calcium or creatinine levels.
Conclusions
VDD was seen in nearly 25% of MGH FLS patients and more prevalent in male and younger patients. VDD was associated with longer LOS and higher 30d-RA risk in patients with hip fracture. Daily 50ku-D2 appeared to be a practical way to quickly replete vitamin D in the inpatient setting.